Research

July 9, 2015

Signals of schizophrenia

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder.

By VUMC News and Communications
July 9, 2015

Study could lead to vaccine for mosquito-borne dengue virus

Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.

By Bill Snyder
July 8, 2015

Vanderbilt researchers develop potential treatment to fight mosquito-borne chikungunya virus

In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States.

By Nancy Humphrey
June 11, 2015

Study: Why one kidney can work as well as two

Vanderbilt University researchers have come closer to solving a mystery that has puzzled scientists for more than a century: after the loss of one kidney, what causes the growth of the remaining kidney to take up the slack?

By Bill Snyder
HIV cell
May 21, 2015

‘Redesigned’ antibodies may control HIV: study

With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.

By Bill Snyder
May 14, 2015

Insights on lysosomal storage diseases

A novel mechanism could point to new therapies for a group of inherited diseases that share pathological features.

By Leigh MacMillan
May 7, 2015

Peek named editor-in-chief of leading gastroenterology journal

Richard Peek, M.D., director of the Vanderbilt Digestive Disease Research Center, has been appointed to a five-year term as editor-in-chief of the medical journal Gastroenterology beginning July 2016.
By Bill Snyder
April 30, 2015

Team tracks how kidney responds to blood pressure meds

Changes in the kidney can limit the blood pressure-lowering effects of thiazide diuretics, a new study reports.
By Leigh MacMillan
April 2, 2015

Gene variant, environment can boost RSV severity

A particular genetic mutation combined with an urban environment increases the risk of severe disease in children infected with respiratory syncytial virus (RSV), an international team of investigators has found.
By Leigh MacMillan
March 26, 2015

Nominations for Vanderbilt Prize Scholar sought

Nominations for this year’s Vanderbilt Prize Scholar are now being accepted. The deadline is April 24.
By Doug Campbell
March 12, 2015

Gene mutations may predict melanoma response to immunotherapies

Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators.
By VUMC News and Communications
March 3, 2015

Study shows poor heart function could be major Alzheimer’s disease risk

A healthier heart could prevent Alzheimer’s disease, according to new research at Vanderbilt University Medical Center.
By VUMC News and Communications
February 26, 2015

Studies show human antibodies can fight lethal Marburg virus

Researchers at Vanderbilt University, the University of Texas Medical Branch at Galveston and The Scripps Research Institute for the first time have shown how human antibodies can neutralize the Marburg virus, a close cousin to Ebola.
By Bill Snyder
1 … 105 106 107 108 109 … 125